Role of Svayambhuva Guggulu and Ketakyadi Taila Nasya in management of cervical spondyosis

Efficacy of Svayambhuva Guggulu and Ketakyadi Taila Nasya in management of Manyastambha(Cervical Spondylosis): A Single Arm Open Labelled Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041556

Enrollment

Registered

2022-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having clinical features of cervical spondylosis 2 Age group - 18-70 years 3 Patient eligible for Nasya 4 Patients willing to accept the participation in the clinical trial

Exclusion criteria

Exclusion criteria: 1 Age below 18 years and above 70 years. 2 Associated conditions like fibrositis, rheumatoid arthritis, ankylosing spondylitis etc. 3 Patients with uncontrolled DM (RBS > 200 mg/dl), HTN (160/100 mm Hg), T.B of cervical spine, nasal polyps, serious psychiatric or somatic disease. 4 Pregnant and lactating mothers. 5 Patients not suitable for Nasya. 6 Patients with any previous cervical fracture or cervical spine surgery. 7 Patients having signs of myelopathy, infection, active cancer. 8 Patients having Grade 4 changes as per Kellgren and Lawrence Scale.

Design outcomes

Primary

Measure	Time frame
To manage the pain and improvement of signs and symptoms of cervical spondylosis.Timepoint: on 0 day and after 8 weeks	—

Secondary

Measure	Time frame
To improve the quality of life in patient of cervical spondylosis.Timepoint: on 0 day and after 8 weeks	—

Countries

India

Contacts

Public ContactDr Mandip Goyal

I.T.R.A . Jamnagar

deanacademic@itra.edu.in9426433231

Outcome results